A description of the journey of a family with a child with sickle cell disease who emigrated from Togo to Germany.
C2C contributed to an article on Sickle Cell Disease treatment in the prestigious medical journal Lancet Haematology.
On Sunday December 6 2020, Dr. Haydar Frangoul from Tristar Children's Hospital, Nashville, TN, USA, presented preliminary results of gene editing for the cure of Thalassemia and sickle cell disease.
Our experience in BMT services set up in middle income countries drives European Blood and Marrow Transplantation group stand on the approach to the cure of pediatric disorder in reduced resources settings..
First allogeneic transplant in Armenia